Yemaachi Biotech, a pioneering genomics research company based in Ghana and Illumina, a global leader in sequencing technology, have announced, the arrival of the NovaSeq X Plus in Ghana to accelerate research that promises to reduce inequities in cancer care in African population.The first of its kind in the country, NovaSeq X Plus is the most powerful sequencer manufactured by Illumina yet, to Ghana."The NovaSeq X Plus can generate more than double the number of genomes of our prior sequencers.
It has unprecedented speed, scale and accuracy and pushes the limits on what is possible with genetic sequencing.
With NovaSeq X Plus, Yemaaachi is well positioned to reach their goals more quickly to help transform the lives of cancer patients." Illumina Country Manager-Africa, Bridget Mogale, said in a statement issued by the company."At Illumina, we are driven by the power of genomics to positively impact the world and are deeply committed to improving global health.
We are pleased to have Yemaachi bring in this powerful sequencer to better understand cancers in populations of African descent and address existing disparities in current data sets.
